Related Experiment Video
Updated: Oct 28, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Risk stratification in cardiogenic shock: a focus on the available evidence.
C Sciaccaluga1, G E Mandoli2, N Ghionzoli2
1Department of Medical Biotechnologies, Section of Cardiology, University of Siena, Siena, Italy. carlotta.sciaccaluga@gmail.com.
Cardiogenic shock is a serious condition with high mortality. Early risk stratification using clinical, lab, and echo data improves patient outcomes and resource allocation.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a life-threatening condition caused by a primary cardiac disorder leading to hypotension and organ hypoperfusion.
- CS is associated with a high mortality rate, necessitating urgent diagnosis and treatment.
- Effective risk stratification is crucial for optimizing patient management and resource allocation.
Purpose of the Study:
- To critically analyze current evidence on prognostic parameters in cardiogenic shock.
- To evaluate the strengths and limitations of existing prognostic scores for CS.
- To provide insights into future directions for improving risk stratification in CS patients.
Main Methods:
- Systematic review of existing literature on cardiogenic shock prognosis.
- Analysis of clinical, laboratoristic, and echocardiographic prognostic parameters.
- Evaluation of established prognostic scoring systems in CS.
Main Results:
- Identified key clinical, laboratory, and echocardiographic factors predictive of outcomes in CS.
- Assessed the utility and limitations of current prognostic scores.
- Highlighted variability in prognostic accuracy among different parameters and scores.
Conclusions:
- Accurate risk stratification in cardiogenic shock is essential for guiding treatment intensity and resource allocation.
- A combination of clinical, laboratory, and echocardiographic data offers the most comprehensive prognostic assessment.
- Further research is needed to refine prognostic models and improve early identification of high-risk CS patients.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care

